To evaluate cancer-specificity, the promoter methylation levels of RASSF1A, DAPK1, SOX1, HOXA9, HIC1, SPARC, and SFRP1 were quantitatively analyzed by MethyLight in singleplex and multiplex assays. This evidence concerns the gene DAPK1 and cancer.